Committees
Financial disclosures of interest for committee members, updated November 2017:
Name |
Entity |
Relationship |
Benefit to individual |
Benefit to institution |
|---|---|---|---|---|
Steering Committee |
||||
|
Richard Hillman (ASHA) |
Merck Sharpe & Dohme | Consultancy, Grants/grants pending, Honoraria, Travel/accommodation expenses covered or reimbursed | X | |
| CSL | Grants/grants pending, Honoraria, Travel/accommodation expenses covered or reimbursed | X | ||
| Hologic | Grants/grants pending | X | ||
| Douglass Hanley Moir | Grants/grants pending | X | ||
| Gilead | Payment for development of educational presentations including service on speakers’ bureaus, Travel/accommodation expenses covered or reimbursed | X | ||
| Janssen | Payment for development of educational presentations including service on speakers’ bureaus, Travel/accommodation expenses covered or reimbursed | X | ||
| Boehringer Ingelheim | Travel/accommodation expenses covered or reimbursed | X | ||
|
Chris Bourne (AChSHM) |
Nothing to declare. | |||
|
Catherine Engelke (AIDA) [From March 2014] |
No disclosures provided. | |||
| Christopher Fairley (ASID) | Merck Sharpe & Dohme | Grants/grants pending Honoraria |
X | X |
| bioCSL | Stock/stock options, Travel/accommodation expenses covered or reimbursed, Honoraria |
X | X | |
|
Catherine Henderson (AIDA) [Until March 2014] |
Nothing to declare. | |||
| Lewis Marshall (Expert with guideline development experience) | GlaxoSmithKline | Payment for development of educational presentations including service on speakers’ bureaus | X | |
| CSL | Payment for development of educational presentations including service on speakers’ bureaus, Travel/accommodation expenses covered or reimbursed |
X | ||
| Novartis | Payment for development of educational presentations including service on speakers’ bureaus, Travel/accommodation expenses covered or reimbursed | X | ||
|
Ron McCoy (RACGP) |
Nothing to declare. | |||
| Kathy McNamee (FPA) | Merck Sharpe & Dohme | Honoraria, Payment for development of educational presentations including service on speakers’ bureaus, Travel/accommodation expenses covered or reimbursed |
X | |
| Bayer Health | Paid per participant at independently developed training. | X | ||
| Joanne Perks (APNA / ACNP) | Nothing to declare. | |||
| Darren Russell (ASHM) | Janssen | Honoraria | X | |
| Gilead | Honoraria | X | ||
| Merck Sharpe & Dohme | Honoraria | X | ||
| Abbott | Honoraria | X | ||
| ViiV | Payment for development of educational presentations including service on speaker’s bureaus | X | ||
|
Simon Powell (APNA) [Until October 2013] |
Nothing to declare. | |||
| Meredith Temple-Smith (Expert with guideline development experience) |
Nothing to declare. | |||
| Suzanne Werder (ASHA) | Nothing to declare. | |||
Editorial Subcommittee |
||||
| Chris Bourne | As above. | |||
| Vickie Knight | Nothing to declare. | |||
| Lewis Marshall | As above. | |||
| Ron McCoy | As above. | |||
| Sepehr Tabrizi | Nothing to declare. | |||
| Meredith Temple-Smith | As above. | |||
| James Ward | No disclosures provided. | |||